Huge story for the UK - FT scoop here on AstraZeneca in talks to combine with US rival Bristol Myers Squibb. AZN is the second biggest listed UK company and would be the bigger party in a deal. But could it redomicile to the US as part of a deal? www.ft.com/content/e902...
AstraZeneca holds talks with Bristol Myers Squibb over $400bn tie-up
Deal would create world’s fourth-largest drugmaker by market value
ft.com